Company Active LTD

Company profile

Oxford Biotherapeutics Ltd

UK company 04974481, incorporated on 24 November 2003.

www.oxfordbiotherapeutics.com

OxfordBioTherapeutics

Company number
04974481
Incorporated
24 Nov 2003
Companies House status
Active

Company identity

Founded / incorporated
24 November 2003

Company number 04974481

Verify at Companies House
Legal name
OXFORD BIOTHERAPEUTICS LTD
Company type
Private Limited Company
Region
South East England
Registered address
SUITE A, SECOND FLOOR, THE SCHRODINGER BUILDING HEATLEY ROAD
OXFORD SCIENCE PARK
OXFORD
UNITED KINGDOM
OX4 4GE
Insolvency history
No

Corporate ownership

Updated 07 Jul 2026 09:49

11 levels 3 ultimate controllers
1
Company Active LTD
Oxford Biotherapeutics Ltd
CRN 04974481
2
Direct controller Active LTD
3
Direct controller Active LTD
4
Intermediate controller Active PRIVATE-LIMITED-GUARANT-NSC
5
Intermediate controller Active LTD
6
Intermediate controller Active LTD
7
Intermediate controller Active LTD
8
Ultimate controller Active LTD
Wme Group Limited
CRN 06855978
9
Ultimate controller Active LTD
10
Intermediate controller Active LLP
Barnett Waddingham LLP
CRN OC307678
11
Intermediate controller Active LTD
12
Intermediate controller Active LTD
13
Intermediate controller Active LTD
14
Intermediate controller Active LTD
HGH Midco 3 Limited
CRN 13646017
15
Intermediate controller Active LTD
Hig Finance 2 Limited
CRN 10842605
16
Intermediate controller Active LTD
HGH Finance Limited
CRN 13645436
17
Intermediate controller Active LTD
HGH Midco 2 Limited
CRN 13644440
18
Intermediate controller Active LTD
HGH Midco 1 Limited
CRN 13642978
19
Ultimate controller Active LTD

Latest accounts

Financial period: 1 Jan 2024 to 31 Dec 2024

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
£3,560,161
Employees
4,958,396

Company events

Reference milestones and recent Companies House filing stream events.

7 events
10 Jun
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

09 Jun
2026

Confirmation Statement With Updates

Confirmation-statement

CS01 | Transaction MzUyNjAzMDkyOWFkaXF6a2N4

Published 09 Jun 2026 11:55

08 Jun
2026

Change To A Person With Significant Control

Persons-with-significant-control

PSC05 | Transaction MzUyNTkzMjY3OWFkaXF6a2N4

Published 08 Jun 2026 16:50

27 May
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

24 Nov
2003

Incorporated

Inception

Company registered at Companies House

Public funding

1 award
First funded
2007
Funded years
2007
Age at first award
3 years

Projects

2007 Collaborative R&D Lead participant

Drug safety protein biomarker.

1 Apr 2007 to 31 Mar 2010

Awarded
£783,635
Total cost £1,567,270

To establish a hepatotoxicity biomarker database in zebrafish embryos (ZFEs) using compounds with known toxicities. To use this database in parallel with OGeS''s existing OGAP database to select and validate potential drug safety protein biomarkers in both ZFEs and rodents (and ultimately, man). To develop highthroughput Ordered Peptide Array (OPA) screen...

Product types

Collaborative R&D